Prescription drugs, medical devices boost J&J in Q4
Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well By TOM MURPHY AP … Read More
![]()

